(Q39544576)

English

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.

scientific article published on April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Robert E Widdop

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lotte Bjerre Knudsen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Tracey Gaspari

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

HongBin Liu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Iresha Welungoda

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yunshan Hu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Richard W Simpson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

117-124

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562063%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Type-2 diabetes mellitus related cardiovascular risk: new options for interventions to reduce risk and treatment goals.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Endothelial dysfunction: the first step toward coronary arteriosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-kappaB activation in bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

The role of incretins in glucose homeostasis and diabetes treatment

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Adhesion molecules and atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.

1 reference

https://api.crossref.org/works/10.1177%2F1479164111404257

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39544576&oldid=1462510301"